US Stock MarketDetailed Quotes

Mirum Pharmaceuticals (MIRM)

Watchlist
  • 102.185
  • -9.205-8.26%
Close May 15 16:00 ET
  • 111.200
  • +9.015+8.82%
Pre 08:10 ET
6.23BMarket Cap-7.51P/E (TTM)

Mirum Pharmaceuticals (MIRM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11,565.63%-228.76M
440.70%55.83M
219.71%6.07M
896.01%39.68M
416.59%12.04M
-112.89%-1.96M
114.55%10.33M
69.50%-5.07M
121.86%3.98M
78.06%-3.8M
Net income from continuing operations
-5,283.63%-790.16M
73.43%-23.36M
75.91%-5.73M
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
Operating gains losses
266.87%1.1M
-39.72%-1.72M
229.53%193K
-163.85%-643K
-72.39%-612K
62.05%-658K
-169.78%-1.23M
-104.98%-149K
--1.01M
---355K
Depreciation and amortization
13.58%6.87M
2.60%24.24M
0.30%6.07M
0.12%6.06M
3.45%6.06M
6.85%6.05M
118.20%23.63M
10.23%6.06M
127.46%6.06M
338.17%5.85M
Deferred tax
----
----
----
----
----
----
--0
----
----
----
Other non cash items
-158.24%-272K
-6.85%2.07M
23.13%511K
45.72%545K
9.22%545K
-49.89%467K
-95.95%2.22M
-19.26%415K
1.91%374K
-99.00%499K
Change In working capital
1,004.83%102.22M
-187.27%-19.72M
-732.76%-14.01M
1,085.80%12.15M
-519.45%-6.56M
-147.18%-11.3M
217.53%22.59M
77.41%-1.68M
78.17%-1.23M
144.66%1.56M
-Change in receivables
23.45%-12.89M
-320.58%-48.06M
-74.96%-19.01M
61.16%-3.15M
-66.97%-9.07M
-229.79%-16.83M
74.02%-11.43M
46.04%-10.86M
35.24%-8.1M
49.08%-5.43M
-Change in inventory
28.14%-1.92M
-166.84%-8.45M
-966.36%-2.28M
-28.35%-1.16M
-115.21%-2.34M
-177.18%-2.67M
-225.05%-3.17M
-117.37%-214K
-105.69%-903K
-9.71%-1.09M
-Change in prepaid assets
-118.88%-6.63M
-577.97%-5.76M
2,094.14%5.99M
-33.60%-4.63M
-386.26%-4.09M
-429.96%-3.03M
76.42%-849K
278.43%273K
-30.09%-3.47M
292.32%1.43M
-Change in payables and accrued expense
387.72%57.24M
24.29%50.1M
-63.13%3.44M
90.92%24.35M
52.32%10.58M
4.08%11.74M
30.98%40.31M
-25.45%9.34M
23.97%12.75M
-24.32%6.94M
-Change in other current assets
-5,113.04%-4.8M
-278.04%-5.66M
-81,750.00%-1.64M
-90.63%-2.68M
-1,162.63%-1.25M
-936.36%-92K
-193.15%-1.5M
99.71%-2K
-2,773.47%-1.41M
-76.79%-99K
-Change in other current liabilities
17,552.70%71.21M
-142.46%-1.9M
-139.72%-513K
-447.17%-580K
-104.66%-395K
-51.67%-408K
16.81%-782K
6.55%-214K
60.45%-106K
13.84%-193K
Cash from discontinued investing activities
Operating cash flow
-11,565.63%-228.76M
440.70%55.83M
219.71%6.07M
896.01%39.68M
416.59%12.04M
-112.89%-1.96M
114.55%10.33M
69.50%-5.07M
121.86%3.98M
78.06%-3.8M
Investing cash flow
Cash flow from continuing investing activities
28.29%-11.57M
73.42%-23.95M
56.94%1.01M
87.65%-2.23M
90.93%-6.6M
-124,007.69%-16.13M
15.93%-90.13M
132.05%641K
90.13%-18.04M
-243.86%-72.72M
Net PPE purchase and sale
-1,519.51%-664K
3.93%-954K
-2,900.00%-600K
-3.31%-187K
83.83%-126K
-215.38%-41K
-811.01%-993K
---20K
---181K
-1,045.59%-779K
Net intangibles purchase and sale
---10M
--0
--0
--0
--0
--0
0.00%-20M
--0
---10M
---10M
Net business purchase and sale
----
--0
----
----
----
----
--0
--0
----
----
Net investment purchase and sale
94.38%-905K
66.73%-23M
142.97%1.61M
74.03%-2.04M
89.55%-6.47M
---16.09M
-155.01%-69.13M
-77.97%661K
-126.18%-7.86M
-222.37%-61.94M
Cash from discontinued investing activities
Investing cash flow
28.29%-11.57M
73.42%-23.95M
56.94%1.01M
87.65%-2.23M
90.93%-6.6M
-124,007.69%-16.13M
15.93%-90.13M
132.05%641K
90.13%-18.04M
-243.86%-72.72M
Financing cash flow
Cash flow from continuing financing activities
4,147.19%270.08M
126.80%40.14M
68.52%9M
316.67%16.1M
19.16%8.69M
427.72%6.36M
-94.74%17.7M
200.51%5.34M
-98.13%3.86M
-93.64%7.29M
Net issuance payments of debt
----
--0
----
----
----
----
--0
--0
--0
----
Net common stock issuance
--259.95M
--0
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
59.32%10.13M
126.80%40.14M
68.52%9M
316.67%16.1M
19.16%8.69M
427.72%6.36M
69.04%17.7M
140.87%5.34M
-18.95%3.86M
247.69%7.29M
Cash from discontinued financing activities
Financing cash flow
4,147.19%270.08M
126.80%40.14M
68.52%9M
316.67%16.1M
19.16%8.69M
427.72%6.36M
-94.74%17.7M
200.51%5.34M
-98.13%3.86M
-93.64%7.29M
Net cash flow
Beginning cash position
33.75%298.17M
-22.14%222.93M
26.46%282.5M
-2.10%228.6M
-29.92%212.25M
-22.14%222.93M
123.69%286.33M
-26.29%223.39M
-21.44%233.5M
102.68%302.84M
Current changes in cash
353.47%29.75M
215.96%72.02M
1,660.35%16.07M
625.57%53.55M
120.41%14.13M
-171.54%-11.74M
-139.19%-62.1M
105.42%913K
-265.78%-10.19M
-146.80%-69.23M
Effect of exchange rate changes
-220.57%-1.27M
348.42%3.22M
70.41%-408K
296.59%349K
1,970.59%2.23M
833.63%1.06M
-875.19%-1.3M
-1,376.85%-1.38M
127.94%88K
-4.39%-119K
End cash Position
53.90%326.64M
33.75%298.17M
33.75%298.17M
26.46%282.5M
-2.10%228.6M
-29.92%212.25M
-22.14%222.93M
-22.14%222.93M
-26.29%223.39M
-21.44%233.5M
Free cash flow
-11,859.39%-239.43M
614.37%54.87M
207.45%5.47M
737.31%39.49M
181.70%11.91M
-113.17%-2M
88.28%-10.67M
76.46%-5.09M
65.99%-6.2M
16.19%-14.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11,565.63%-228.76M440.70%55.83M219.71%6.07M896.01%39.68M416.59%12.04M-112.89%-1.96M114.55%10.33M69.50%-5.07M121.86%3.98M78.06%-3.8M
Net income from continuing operations -5,283.63%-790.16M73.43%-23.36M75.91%-5.73M120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M
Operating gains losses 266.87%1.1M-39.72%-1.72M229.53%193K-163.85%-643K-72.39%-612K62.05%-658K-169.78%-1.23M-104.98%-149K--1.01M---355K
Depreciation and amortization 13.58%6.87M2.60%24.24M0.30%6.07M0.12%6.06M3.45%6.06M6.85%6.05M118.20%23.63M10.23%6.06M127.46%6.06M338.17%5.85M
Deferred tax --------------------------0------------
Other non cash items -158.24%-272K-6.85%2.07M23.13%511K45.72%545K9.22%545K-49.89%467K-95.95%2.22M-19.26%415K1.91%374K-99.00%499K
Change In working capital 1,004.83%102.22M-187.27%-19.72M-732.76%-14.01M1,085.80%12.15M-519.45%-6.56M-147.18%-11.3M217.53%22.59M77.41%-1.68M78.17%-1.23M144.66%1.56M
-Change in receivables 23.45%-12.89M-320.58%-48.06M-74.96%-19.01M61.16%-3.15M-66.97%-9.07M-229.79%-16.83M74.02%-11.43M46.04%-10.86M35.24%-8.1M49.08%-5.43M
-Change in inventory 28.14%-1.92M-166.84%-8.45M-966.36%-2.28M-28.35%-1.16M-115.21%-2.34M-177.18%-2.67M-225.05%-3.17M-117.37%-214K-105.69%-903K-9.71%-1.09M
-Change in prepaid assets -118.88%-6.63M-577.97%-5.76M2,094.14%5.99M-33.60%-4.63M-386.26%-4.09M-429.96%-3.03M76.42%-849K278.43%273K-30.09%-3.47M292.32%1.43M
-Change in payables and accrued expense 387.72%57.24M24.29%50.1M-63.13%3.44M90.92%24.35M52.32%10.58M4.08%11.74M30.98%40.31M-25.45%9.34M23.97%12.75M-24.32%6.94M
-Change in other current assets -5,113.04%-4.8M-278.04%-5.66M-81,750.00%-1.64M-90.63%-2.68M-1,162.63%-1.25M-936.36%-92K-193.15%-1.5M99.71%-2K-2,773.47%-1.41M-76.79%-99K
-Change in other current liabilities 17,552.70%71.21M-142.46%-1.9M-139.72%-513K-447.17%-580K-104.66%-395K-51.67%-408K16.81%-782K6.55%-214K60.45%-106K13.84%-193K
Cash from discontinued investing activities
Operating cash flow -11,565.63%-228.76M440.70%55.83M219.71%6.07M896.01%39.68M416.59%12.04M-112.89%-1.96M114.55%10.33M69.50%-5.07M121.86%3.98M78.06%-3.8M
Investing cash flow
Cash flow from continuing investing activities 28.29%-11.57M73.42%-23.95M56.94%1.01M87.65%-2.23M90.93%-6.6M-124,007.69%-16.13M15.93%-90.13M132.05%641K90.13%-18.04M-243.86%-72.72M
Net PPE purchase and sale -1,519.51%-664K3.93%-954K-2,900.00%-600K-3.31%-187K83.83%-126K-215.38%-41K-811.01%-993K---20K---181K-1,045.59%-779K
Net intangibles purchase and sale ---10M--0--0--0--0--00.00%-20M--0---10M---10M
Net business purchase and sale ------0------------------0--0--------
Net investment purchase and sale 94.38%-905K66.73%-23M142.97%1.61M74.03%-2.04M89.55%-6.47M---16.09M-155.01%-69.13M-77.97%661K-126.18%-7.86M-222.37%-61.94M
Cash from discontinued investing activities
Investing cash flow 28.29%-11.57M73.42%-23.95M56.94%1.01M87.65%-2.23M90.93%-6.6M-124,007.69%-16.13M15.93%-90.13M132.05%641K90.13%-18.04M-243.86%-72.72M
Financing cash flow
Cash flow from continuing financing activities 4,147.19%270.08M126.80%40.14M68.52%9M316.67%16.1M19.16%8.69M427.72%6.36M-94.74%17.7M200.51%5.34M-98.13%3.86M-93.64%7.29M
Net issuance payments of debt ------0------------------0--0--0----
Net common stock issuance --259.95M--0--------------0--0--0--0--0
Proceeds from stock option exercised by employees 59.32%10.13M126.80%40.14M68.52%9M316.67%16.1M19.16%8.69M427.72%6.36M69.04%17.7M140.87%5.34M-18.95%3.86M247.69%7.29M
Cash from discontinued financing activities
Financing cash flow 4,147.19%270.08M126.80%40.14M68.52%9M316.67%16.1M19.16%8.69M427.72%6.36M-94.74%17.7M200.51%5.34M-98.13%3.86M-93.64%7.29M
Net cash flow
Beginning cash position 33.75%298.17M-22.14%222.93M26.46%282.5M-2.10%228.6M-29.92%212.25M-22.14%222.93M123.69%286.33M-26.29%223.39M-21.44%233.5M102.68%302.84M
Current changes in cash 353.47%29.75M215.96%72.02M1,660.35%16.07M625.57%53.55M120.41%14.13M-171.54%-11.74M-139.19%-62.1M105.42%913K-265.78%-10.19M-146.80%-69.23M
Effect of exchange rate changes -220.57%-1.27M348.42%3.22M70.41%-408K296.59%349K1,970.59%2.23M833.63%1.06M-875.19%-1.3M-1,376.85%-1.38M127.94%88K-4.39%-119K
End cash Position 53.90%326.64M33.75%298.17M33.75%298.17M26.46%282.5M-2.10%228.6M-29.92%212.25M-22.14%222.93M-22.14%222.93M-26.29%223.39M-21.44%233.5M
Free cash flow -11,859.39%-239.43M614.37%54.87M207.45%5.47M737.31%39.49M181.70%11.91M-113.17%-2M88.28%-10.67M76.46%-5.09M65.99%-6.2M16.19%-14.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More